515 related articles for article (PubMed ID: 26040247)
21. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z
Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
[TBL] [Abstract][Full Text] [Related]
22. Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR-ABL-positive acute lymphoblastic leukemia.
Mizuta S; Matsuo K; Yagasaki F; Yujiri T; Hatta Y; Kimura Y; Ueda Y; Kanamori H; Usui N; Akiyama H; Miyazaki Y; Ohtake S; Atsuta Y; Sakamaki H; Kawa K; Morishima Y; Ohnishi K; Naoe T; Ohno R
Leukemia; 2011 Jan; 25(1):41-7. PubMed ID: 20944676
[TBL] [Abstract][Full Text] [Related]
23. T cell exhaustion characterized by compromised MHC class I and II restricted cytotoxic activity associates with acute B lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation.
Liu L; Chang YJ; Xu LP; Zhang XH; Wang Y; Liu KY; Huang XJ
Clin Immunol; 2018 May; 190():32-40. PubMed ID: 29477343
[TBL] [Abstract][Full Text] [Related]
24. [Clinical study of allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute lymphocytic leukemia].
Ma X; Wu DP; Sun AN; Fu ZZ; Tang XW; Wu XJ; Liu YJ; Qiu HY; Miao M; Han Y; Jin ZM; Zhao Y; Xue SL; Wang Y; Chen SN; He GS; Zhou HX; Chang HR
Zhonghua Xue Ye Xue Za Zhi; 2009 Feb; 30(2):73-6. PubMed ID: 19563014
[TBL] [Abstract][Full Text] [Related]
25. Graft-versus-leukemia effect on infant lymphoblastic leukemia relapsed after sibling hematopoietic stem cell transplantation.
Boatsman EE; Fu CH; Song SX; Moore TB
J Pediatr Hematol Oncol; 2010 Mar; 32(2):e57-60. PubMed ID: 20168246
[TBL] [Abstract][Full Text] [Related]
26. Comparison of chemotherapeutic agents as a myeloablative conditioning with total body irradiation for pediatric acute lymphoblastic leukemia: A study from the pediatric ALL working group of the Japan Society for Hematopoietic Cell Transplantation.
Kato M; Ishida H; Koh K; Inagaki J; Kato K; Goto H; Kaneko T; Cho Y; Hashii Y; Kurosawa H; Takita J; Hamamoto K; Inoue M; Sawada A; Suzuki R; Kato K
Pediatr Blood Cancer; 2015 Oct; 62(10):1844-50. PubMed ID: 26053959
[TBL] [Abstract][Full Text] [Related]
27. Intravenous busulfan-cyclophosphamide as a preparative regimen before allogeneic hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia.
Tang W; Wang L; Zhao WL; Chen YB; Shen ZX; Hu J
Biol Blood Marrow Transplant; 2011 Oct; 17(10):1555-61. PubMed ID: 21549217
[TBL] [Abstract][Full Text] [Related]
28. [Effects of allogeneic hematopoietic stem cell transplantation with very-high-dose conditioning regimen for refractory leukemia].
Liu QF; Sun J; Xu D; Zhang Y; Fan ZP; Wei YQ; Meng FY; Zhou SY
Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1117-9. PubMed ID: 15485779
[TBL] [Abstract][Full Text] [Related]
29. Haploidentical hematopoietic stem cell transplantation for pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia in the imatinib era.
Chen H; Liu KY; Xu LP; Chen YH; Zhang XH; Wang Y; Qin YZ; Liu YR; Lai YY; Huang XJ
Leuk Res; 2017 Aug; 59():136-141. PubMed ID: 28654842
[TBL] [Abstract][Full Text] [Related]
30. Allogeneic hemopoietic stem cell transplantation for patients with high risk acute lymphoblastic leukemia: favorable impact of chronic graft-versus-host disease on survival and relapse.
Zikos P; Van Lint MT; Lamparelli T; Gualandi F; Occhini D; Bregante S; Berisso G; Mordini N; Incagliato M; Fugazza G; Sessarego M; Bacigalupo A
Haematologica; 1998 Oct; 83(10):896-903. PubMed ID: 9830798
[TBL] [Abstract][Full Text] [Related]
31. Hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia and Down syndrome.
Goto H; Kaneko T; Shioda Y; Kajiwara M; Sakashita K; Kitoh T; Hayakawa A; Miki M; Kato K; Ogawa A; Hashii Y; Inukai T; Kato C; Sakamaki H; Yabe H; Suzuki R; Kato K
Pediatr Blood Cancer; 2015 Jan; 62(1):148-52. PubMed ID: 25262825
[TBL] [Abstract][Full Text] [Related]
32. Decitabine for relapsed acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation.
Cui JK; Xiao Y; You Y; Shi W; Li Q; Luo Y; Jiang L; Zhong ZD
J Huazhong Univ Sci Technolog Med Sci; 2017 Oct; 37(5):693-698. PubMed ID: 29058281
[TBL] [Abstract][Full Text] [Related]
33. Graft-versus-adult T-cell leukemia/lymphoma effect following allogeneic hematopoietic stem cell transplantation.
Yonekura K; Utsunomiya A; Takatsuka Y; Takeuchi S; Tashiro Y; Kanzaki T; Kanekura T
Bone Marrow Transplant; 2008 Jun; 41(12):1029-35. PubMed ID: 18332910
[TBL] [Abstract][Full Text] [Related]
34. [Second allogeneic transplant for leukemia relapsed after first allogeneic transplantation].
Yang DL; Han MZ; Feng SZ; Wang M; Zou DH; Wei JL; Yan ZS; Zhou SY; Liu QG; Jiang EL; Huang Y; Wang HH; Zhou Z; Zhai WJ; Yan WW; Han ZC
Zhonghua Xue Ye Xue Za Zhi; 2004 May; 25(5):285-9. PubMed ID: 15182537
[TBL] [Abstract][Full Text] [Related]
35. Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trial.
Peters C; Schrappe M; von Stackelberg A; Schrauder A; Bader P; Ebell W; Lang P; Sykora KW; Schrum J; Kremens B; Ehlert K; Albert MH; Meisel R; Matthes-Martin S; Gungor T; Holter W; Strahm B; Gruhn B; Schulz A; Woessmann W; Poetschger U; Zimmermann M; Klingebiel T
J Clin Oncol; 2015 Apr; 33(11):1265-74. PubMed ID: 25753432
[TBL] [Abstract][Full Text] [Related]
36. Successful treatment with imatinib-combined chemotherapy for relapsed Philadelphia-positive acute lymphoblastic leukemia after allogeneic bone marrow transplantation.
IMAHASHI N; TOKUNAGA M; NISHIWAKI S; YANAGISAWA M; OZAWA Y; MIYAMURA K
Rinsho Ketsueki; 2009 Nov; 50(11):1612-5. PubMed ID: 20009435
[TBL] [Abstract][Full Text] [Related]
37. Comparative analysis of unrelated cord blood transplantation and HLA-matched sibling hematopoietic stem cell transplantation in children with high-risk or advanced acute leukemia.
Zheng C; Zhu X; Tang B; Yao W; Song K; Tong J; Geng L; Liu H; Sun Z
Ann Hematol; 2015 Mar; 94(3):473-80. PubMed ID: 25217231
[TBL] [Abstract][Full Text] [Related]
38. Allogeneic hematopoietic stem cell transplantation for Philadelphia-positive acute lymphoblastic leukemia in children and adolescents: a retrospective multicenter study of the Italian Association of Pediatric Hematology and Oncology (AIEOP).
Fagioli F; Zecca M; Rognoni C; Lanino E; Balduzzi A; Berger M; Messina C; Favre C; Rabusin M; Lo Nigro L; Masetti R; Prete A; Locatelli F;
Biol Blood Marrow Transplant; 2012 Jun; 18(6):852-60. PubMed ID: 22019726
[TBL] [Abstract][Full Text] [Related]
39. Hematopoietic Stem Cell Transplantation for Adult Philadelphia-Negative Acute Lymphoblastic Leukemia in the First Complete Remission in the Era of Minimal Residual Disease.
Bourlon C; Lacayo-Leñero D; Inclán-Alarcón SI; Demichelis-Gómez R
Curr Oncol Rep; 2018 Mar; 20(4):36. PubMed ID: 29577208
[TBL] [Abstract][Full Text] [Related]
40. Haploidentical hematopoietic stem cell transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia: no difference in the high- and low-risk groups.
Mo XD; Xu LP; Zhang XH; Liu DH; Wang Y; Chen H; Yan CH; Chen YH; Han W; Wang FR; Wang JZ; Liu KY; Huang XJ
Int J Cancer; 2015 Apr; 136(7):1697-707. PubMed ID: 25138425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]